Articles

Page 19 of 21

Activation of interferon signaling pathway in primary effusion lymphoma cells by inhibition of viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus

Authors: Y Zhang, D Patel and S Fan

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P47

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia

Authors: P Velasco, L Dutcher, DA Davis and R Yarchoan

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P45

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV

Authors: P Unemori, P Hunt, K Leslie, E Sinclair, S Deeks, J Martin and T Maurer

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P43

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770

Authors: TS Uldrick, A Mosam, F Shaik, G Friedland, D Skadden, JP Jordaan, J Aboobaker and HM Coovadia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P41

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Exploring Kaposi's sarcoma-associated herpesvirus latent genes' role in viral lymphomagenesis using transgenic mice

Authors: S-H Sin, FD Fakhari and DP Dittmer

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P39

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Kaposi's sarcoma human herpesvirus K1 interferes with FAS-mediated apoptosis and stimulates clonal growth and lymphoid hyperplasia

Authors: F Samaniego, Z Berkova, H Maeng, S Wang and J Wise

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P37

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
HIV-associated bladder cancer: diagnosis and management

Authors: L Pantanowitz, EM Gaughan, BJ Dezube, M Bower and D Aboulafia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P34

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Colon adenocarcinoma in HIV infected patients

Authors: C Chapman, D Aboulafia, BJ Dezube and L Pantanowitz

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P32

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Extracellular matrix promotes pathogenic treatment of AIDS-associated Kaposi's sarcoma at Hôpital General in Yaoundé, Cameroon

Authors: P Ndom, ZK Bissek, C Takouchop, MT Obama, G Bengono and RW Ryder

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P30

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Genetic resistance to GAHV-2 induced lymphoma in the chicken model

Authors: MM Miller, Y Wang, RM Goto, PS Wakenell and RI Taylor Jr

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P28

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Genetically restricted HIV-1 sub populations are associated with and migrate within metastatic sites of AIDS-related lymphoma

Authors: MS McGrath, M Salemi, R Grey, D Galligan and SL Lamers

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P27

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
MDM2-dependent inhibition of P53 is required for Epstein-Barr virus B cell growth transformation and infected cell survival

Authors: E Forte and MA Luftig

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P26

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Tobacco, alcohol and use of other recreational drugs within HIV-infected treated cohorts: the IeDEA West Africa collaboration

Authors: A Jaquet, DK Ekouevi, J Bashi, M Aboubakrine, E Messou, M Maiga, D Zannou, C Guei, O Ba-Gomis, A Minga, G Allou, J Sasco and F Dabis

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P24

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Expression and function of the chemokine, CXCL13, and its receptor, CXCR5, in AIDS-associated non-Hodgkin's lymphoma

Authors: DP Widney, D Gui, JW Said, EC Breen, R Detels and O Martinez-Maza

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O24

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Trends in cancer incidence among HIV-infected persons in California, 1996–2006

Authors: MJ Silverberg, WA Leyden, C Chao, M Horberg, D Klein, W Towner and DI Abrams

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O22

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Burkitt lymphoma in Brazil is characterized by geographically distinct clinico-pathological features and lack of p53 mutations

Authors: E Queiroga, G Gualco, L Weiss, D Dittmer, I Araujo, C Klumb, W Harrington Jr, E Os and C Bacchi

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P22

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)

Authors: R Yarchoan, D O'Mahony, K Aleman, KM Wyvill, D Whitby, W Bernstein, S Pittaluga, ES Jaffe, G Tosato, DA Davis, SM Steinberg and RF Little

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O20

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
KSHV seroprevalence, and blood and saliva viral loads in the HIV-infected population of south Texas

Authors: M Guadalupe, Y Flahive, S Westbrook, S Redding, D Bullock, V Sankar, B Agan, S Barbieri, CK Yeh, H Dang and SJ Gao

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P20

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Preliminary findings on cancer incidence in HIV-infected persons from six countries in Central and South America and the Caribbean

Authors: DR Masys, F Fang, I Ye, V Fink, E Gotuzzo, D Padgett, JW Pape, C Cortes, M Bacon and M Schechter

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O18

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Kaposi's sarcoma-associated herpes virus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin

Authors: LW Qian, W Greene, FC Ye and SJ Gao

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P18

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation

Authors: JN Martin, M Laker, A Kambugu, D Janka, J Orem, A Mwaka, T Maurer and EK Mbidde

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O17

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer

Authors: PW Nowicki, WC Spanos, DW Lee, ME Anderson, AJ Hoover and JH Lee

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O16

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo

Authors: AL Dufresne, D Fu and RF Ambinder

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P16

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study

Authors: E Lanoy, JP Spano, F Bonnet, F Boué, C Katlama and D Costagliola

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O15

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)

Authors: A Krishnan, J Zaia, J Alvarnas, N Kogut, J Cai, A Nademanee, J Palmer, N Tsai and SJ Forman

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O14

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS malignancies consortium clinical trials 010 and 034

Authors: A Chadburn, A Chiu, Y Lee, X Chen, E Hyjek, A Banhmam, A Noy, A Kaplan, J Sparano, K Bhatia and E Cesarman

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P14

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma

Authors: P Lu, C Yang, I Guasparri, W Harrington, YL Wang and E Cesarman

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P13

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses

Authors: P Gasperini and G Tosato

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O12

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Regulatory T cells are present in Kaposi's sarcoma and increasingly frequent in advanced disease

Authors: D Camarillo, K Leslie, P Unemori, A Koba Yashi, K McCune-Smith and T Maurer

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P12

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Epidemiology of non-keratinocytic skin cancers among persons with AIDS in the United States

Authors: E Lanoy, GM Dores, MM Madeleine, JR Toro, JF Fraumeni and EA Engels

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O10

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Survival and prognosis of HIV-associated non-Hodgkin-lymophma in the era of combined anti-retroviral therapy, a European multi-cohort study

Authors: J Bohlius

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P10

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Dendritic cell-mediated infection of primary B cells with KSHV

Authors: R Bagni, E Barsov, B Ortiz-Conde, D Dittmer, V Kewalramani, D Ott, C Sadowski, P Tuma, F Ruscetti and D Whitby

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P9

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab

Authors: K Dunleavy, RF Little, AS Wayne, N Grant, S Pittaluga, ES Jaffe, S Steinberg, R Yarchoan, J Carrasquillo, J Janik and WH Wilson

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O9

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Evaluation of Epstein-Barr virus (EBV) and human herpes virus-8 (HHV-8) in HIV-associated persistent generalized lymphadenopathy (PGL)

Authors: LW Ayers, G Dominguez and K Bhatia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P7

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting

Authors: LW Ayers, M Ogwang, W Zhou, SM Mbulaiteye and K Bhatia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P6

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

Authors: GM Clifford, M Rickenbach and S Franceschi

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O6

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy

Authors: HQ Nguyen, F Okuku, F Ssewankambo, AS Magaret, C Johnston, A Wald, A Kambugu, L Corey, J Orem and C Casper

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O5

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Suppression of galectin-3 in KSHV infected DMVEC cells and Kaposi's sarcoma: implications for tumorigenesis

Authors: DJ Alcendor, WQ Zhu, P Desai and GS Hayward

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P5

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
A population-based study of how children are exposed to saliva in Africa: implications for KSHV transmission

Authors: LM Butler, S Mzolo, A Mosam and JN Martin

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O4

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

Authors: M Bruyand, R Thiebaut, F Dabis, S Lawson-Ayayi, P Joly, AJ Sasco, P Mercie, JL Pellegrin, S Geffard, D Neau, P Morlat, G Chene and F Bonnet

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O3

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Four year survival in untreated AIDS related-Kaposi sarcoma (AIDS-KS) in Jos, Nigeria

Authors: P Agaba, E Anya, Z Hassan, L Apena, O Agbaji, M Mua'Zu, B Badung and J Idoko

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P3

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study

Authors: J Bohlius

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O2

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Development and application of a real time PCR assay for detection and quantification of merkel cell virus (MCV) in archived formalin fixed paraffin embedded tissue samples of merkel cell carcinoma and other cancers

Authors: R Modali, J Goedert, E Engels, LW Ayers and K Bhatia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):O1

Content type: Oral presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
A retrospective analysis of HIV-associated Kaposi's sarcoma in patients with non-detectable HIV viral loads and CD4+ counts greater than 300 cells/μL

Authors: D Mani and D Aboulafia

Citation: Infectious Agents and Cancer 2009 4(Suppl 2):P1

Content type: Poster presentation Published on: 17 June 2009

This article is part of a Supplement: Volume 4 Supplement 2
- View Full Text
- View PDF
Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy

Women infected with human immunodeficiency virus (HIV) may be at higher risk of developing cervical cancer than non infected women. In a pilot study, we assessed the relationships among cervical cytology abnor...

Authors: Martin Luther Koanga Mogtomo, Louise Carole Gouabe Malieugoue, Carolle Djiepgang, Michel Wankam, Andre Moune and Annie Ngono Ngane

Citation: Infectious Agents and Cancer 2009 4:9

Content type: Research article Published on: 3 June 2009
- View Full Text
- View PDF
Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

Virtually all cases of cervical cancer are caused by persistent infections with a restricted set of human papillomaviruses (HPV). Some HPV types, like HPV16 and HPV18, are clear and powerful carcinogens. Howev...

Authors: Mark Schiffman, Gary Clifford and Franco M Buonaguro

Citation: Infectious Agents and Cancer 2009 4:8

Content type: Review Published on: 1 June 2009
- View Full Text
- View PDF
The evolving definition of carcinogenic human papillomavirus

Thirteen human papillomavirus (HPV) genotypes have been judged to be carcinogenic or probably carcinogenic, and the cause of virtually all cervical cancer worldwide. Other HPV genotypes could possibly be invol...

Authors: Philip E Castle

Citation: Infectious Agents and Cancer 2009 4:7

Content type: Commentary Published on: 11 May 2009
- View Full Text
- View PDF
Analysis of colorectal cancers for human cytomegalovirus presence

A possible association between human cytomegalovirus (HCMV) infection and colorectal cancer progression has been inferred by the identification in tumour tissues of HCMV antigens and specific viral DNA or RNA ...

Authors: Cecilia Bender, Donato Zipeto, Carlo Bidoia, Silvia Costantini, Alberto Zamò, Fabio Menestrina and Umberto Bertazzoni

Citation: Infectious Agents and Cancer 2009 4:6

Content type: Research article Published on: 16 April 2009
- View Full Text
- View PDF
Erratum to: Antiviral therapy in acute viral hepatitis B: why and when

Correction to Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O: Antiviral therapy in acute viral hepatitis B: why and when. Infectious Agents and Cancer 2009, 4:2.

Authors: Giuseppe Morelli, Alessandro Perrella, Costanza Sbreglia, Pasquale Bellopede, Vincenzo Riccio, Antonio Monaco and Oreste Perrella

Citation: Infectious Agents and Cancer 2009 4:5

Content type: Erratum Published on: 1 April 2009

The original article was published in Infectious Agents and Cancer 2009 4:2
- View Full Text
- View PDF
Cancer risk in persons with HIV/AIDS in India: a review and future directions for research

India has a large and evolving HIV epidemic. Little is known about cancer risk in Indian persons with HIV/AIDS (PHA) but risk is thought to be low.

Authors: Robert J Biggar, Anil K Chaturvedi, Kishor Bhatia and Sam M Mbulaiteye

Citation: Infectious Agents and Cancer 2009 4:4

Content type: Review Published on: 28 March 2009
- View Full Text
- View PDF

How was your experience today?

Rating Please select one rating

Awful

Bad

Good

Great

Thank you for your feedback.

Tell us why (opens in a new tab)

Articles

Affiliated with

Follow

Annual Journal Metrics

Infectious Agents and Cancer

Contact us